2019
DOI: 10.1111/cns.13210
|View full text |Cite
|
Sign up to set email alerts
|

Effect of single‐session transcranial direct current stimulation on cognition in Parkinson's disease

Abstract: AimsNonmotor symptoms (NMS) such as cognitive impairment and impulse‐control disorders in Parkinson's disease (PD) remain a therapeutic challenge. Transcranial direct current stimulation (tDCS) has emerged as a promising alternative, although its immediate effects on NMS have been less well defined. In this randomized, sham‐controlled, crossover study, we aimed to explore the single‐session tDCS effects on cognitive performance in PD.MethodsTen nondemented patients with PD completed two sessions in counterbala… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
21
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(22 citation statements)
references
References 39 publications
(87 reference statements)
0
21
0
Order By: Relevance
“…Study subjects had mild to moderate PD (Hoehn and Yahr (H&Y) range = 1.6–2.5). Two studies tested patients off dopaminergic medication [ 26 , 30 ] and three did not report medication status [ 24 , 27 , 32 ]. The study designs were heterogeneous: two studies were open-label (no subject or researcher blinding) [ 28 , 29 ]; three were parallel arm, randomized, double-blind, sham-controlled designs [ 25 , 27 , 32 ]; and four were crossover, randomized, sham-controlled designs, with two being double-blind [ 24 , 26 ], one being single-blind (subject) [ 31 ], and one with unstated blinding [ 30 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Study subjects had mild to moderate PD (Hoehn and Yahr (H&Y) range = 1.6–2.5). Two studies tested patients off dopaminergic medication [ 26 , 30 ] and three did not report medication status [ 24 , 27 , 32 ]. The study designs were heterogeneous: two studies were open-label (no subject or researcher blinding) [ 28 , 29 ]; three were parallel arm, randomized, double-blind, sham-controlled designs [ 25 , 27 , 32 ]; and four were crossover, randomized, sham-controlled designs, with two being double-blind [ 24 , 26 ], one being single-blind (subject) [ 31 ], and one with unstated blinding [ 30 ].…”
Section: Resultsmentioning
confidence: 99%
“…Two studies tested patients off dopaminergic medication [ 26 , 30 ] and three did not report medication status [ 24 , 27 , 32 ]. The study designs were heterogeneous: two studies were open-label (no subject or researcher blinding) [ 28 , 29 ]; three were parallel arm, randomized, double-blind, sham-controlled designs [ 25 , 27 , 32 ]; and four were crossover, randomized, sham-controlled designs, with two being double-blind [ 24 , 26 ], one being single-blind (subject) [ 31 ], and one with unstated blinding [ 30 ]. All but one study administered tDCS with intensities ≤ 2 mA (range of current densities = 0.03 mA/cm 2 – 0.08 mA/cm 2 ) for 15–25 min (mode = 20 min) and targeted frontal brain areas (i.e., the dorsolateral prefrontal cortex (DLPFC), frontal polar area) [ 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 ]; the other study used 2 and 4 mA intensities for 20 min and targeted the cerebellum [ 24 ].…”
Section: Resultsmentioning
confidence: 99%
“…Lau et al ( 29 ) applied 2 mA to the L-DLPFC in 10 subjects with PD without cognitive compromise, locating the cathode in SOAC. The researchers evaluated VWM and emotional inhibitory control using experimental paradigms.…”
Section: Resultsmentioning
confidence: 99%
“…For each analysis, a z -test was performed to derive a summary p -value. Lau et al's ( 29 ) study was excluded since needed data for effect-size calculation could not be extracted, while a social cognition meta-analysis could not be performed because Adenzato et al's ( 30 ) study was the only one to provide such measure.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation